Human immunodeficiency virus (HIV) protease inhibitors have no effect on hepatitis C virus (HCV) serum levels of HIV-HCV co-infected patients.

Matsiota-Bernard, P; Vrioni, G; Onody, C; Bernard, L; de Truchis, P; Peronne, C

Matsiota-Bernard, P; Vrioni, G; Onody, C; Bernard, L; de Truchis, P; Peronne, C.

Affiliation

Matsiota-Bernard P; Laboratoire de Microbiologie, Hôpital Raymond Poicaré, Faculté de Medecine Paris-Ouest, Université Paris V, Paris, France. pmats@cc.uoa.gr

Int J Antimicrob Agents ; 17(2): 155-7, 2001 Feb.

Article in En | MEDLINE | ID: mdl-11165122

Subject(s)

Antiretroviral Therapy, Highly Active; HIV Infections/complications; HIV Protease Inhibitors/therapeutic use; Hepacivirus/drug effects; Hepatitis C/complications; Hepatitis C/virology; CD4 Lymphocyte Count; HIV/drug effects; HIV/physiology; HIV Infections/drug therapy; HIV Infections/immunology; HIV Infections/virology; Hepacivirus/physiology; Hepatitis C/drug therapy; Hepatitis C/immunology; Humans; Indinavir/therapeutic use; RNA, Viral/blood; Reverse Transcriptase Inhibitors/therapeutic use; Ritonavir/therapeutic use; Viral Load; Viremia/virology; Virus Replication/drug effects

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Hepatitis C / HIV Protease Inhibitors / Hepacivirus / Antiretroviral Therapy, Highly Active Limits: Humans Language: En Journal: Int J Antimicrob Agents Year: 2001 Document type: Article

Search on Google

XML

PubMed Links